Your browser doesn't support javascript.
loading
MiRNA-34a reversed TGF-ß-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
Huang, Guanhong; Du, Ming-Yu; Zhu, Hongming; Zhang, Nan; Lu, Zhi-Wei; Qian, Lu-Xi; Zhang, Wenjun; Tian, Xiaokang; He, Xia; Yin, Li.
Afiliación
  • Huang G; Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institue of Cancer Research, 42 Bai Zi Ting Road, Nanjing, Jiangsu, 210000, China; Lianyungang Second People's Hospital, Lianyungang, China.
  • Du MY; Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institue of Cancer Research, 42 Bai Zi Ting Road, Nanjing, Jiangsu, 210000, China.
  • Zhu H; Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institue of Cancer Research, 42 Bai Zi Ting Road, Nanjing, Jiangsu, 210000, China.
  • Zhang N; Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institue of Cancer Research, 42 Bai Zi Ting Road, Nanjing, Jiangsu, 210000, China.
  • Lu ZW; Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institue of Cancer Research, 42 Bai Zi Ting Road, Nanjing, Jiangsu, 210000, China.
  • Qian LX; Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institue of Cancer Research, 42 Bai Zi Ting Road, Nanjing, Jiangsu, 210000, China.
  • Zhang W; Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institue of Cancer Research, 42 Bai Zi Ting Road, Nanjing, Jiangsu, 210000, China.
  • Tian X; Xuzhou Medical University, 209 Tong-Shan Road, Xuzhou, Jiangsu, China.
  • He X; Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institue of Cancer Research, 42 Bai Zi Ting Road, Nanjing, Jiangsu, 210000, China. Electronic address: hexiabm@163.com.
  • Yin L; Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institue of Cancer Research, 42 Bai Zi Ting Road, Nanjing, Jiangsu, 210000, China. Electronic address: yinli_2012@126.com.
Biomed Pharmacother ; 106: 217-224, 2018 Oct.
Article en En | MEDLINE | ID: mdl-29960168
ABSTRACT
Epithelial-mesenchymal transition (EMT) is considered a prerequisite for tumor invasion and metastasis in many cancers. However, the mechanisms underlying EMT in nasopharyngeal carcinoma (NPC) is largely unknown. In this study, we found that transforming growth factor-ß (TGF-ß), which reportedly promotes EMT in multiple cancers, can trigger EMT and increase the invasive and migratory capacities of NPC cells. Conversely, the downregulation of SMAD4, a vital member of the canonical TGF-ß pathway, reversed the TGF-ß-induced EMT, invasion, and migration. Further experiments revealed that SMAD4 was the target of miRNA-34a, which was downregulated in NPC tissues and suppressed NPC cell metastasis in vivo. miRNA-34a overexpression also antagonized the TGF-ß-induced EMT progression, invasion, and migration through SMAD4 inhibition. However, the restoration of SMAD4 expression rescued the inhibitory effects of miRNA-34a on tumorigenesis. All these results confirmed that miRNA-34a suppressed the TGF-ß-induced EMT, invasion, and migration of NPC cells by directly targeting SMAD4, which indicated the potential of miR-34a as a therapeutic target against NPC.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Neoplasias Nasofaríngeas / Factor de Crecimiento Transformador beta / MicroARNs / Proteína Smad4 / Transición Epitelial-Mesenquimal Límite: Animals / Humans / Male Idioma: En Revista: Biomed Pharmacother Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Neoplasias Nasofaríngeas / Factor de Crecimiento Transformador beta / MicroARNs / Proteína Smad4 / Transición Epitelial-Mesenquimal Límite: Animals / Humans / Male Idioma: En Revista: Biomed Pharmacother Año: 2018 Tipo del documento: Article País de afiliación: China